Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor.
The aim of this work was to assess, in vitro and in vivo, the interference of ascorbate and acetaminophen on glucose measurements by a needle-type glucose sensor detecting hydrogen peroxide generated during the enzymatic oxidation of glucose, and to ascertain whether the protection against interference by the membranes used in the construction of the electrode is feasible. The oxidation of ascorbate and acetaminophen on a platinum electrode set at a 650 mV potential yielded a current representing 75 +/- 5% and 25 +/- 6% of that generated by the oxidation of an equimolar concentration of hydrogen peroxide, respectively. The bias introduced by the presence of 100 mumol l-1 ascorbate on the reading of 5 mmol l-1 glucose by the complete sensor (electrode + membranes) would be minimal (approximately 0.4 mmol l-1). By contrast, the bias introduced by 200 mumol l-1 of acetaminophen (a plasma concentration easily reached in clinical practice) was about 7 mmol l-1. The sensor was implanted subcutaneously in anaesthetized rats (n = 3). Using the current generated in the presence of a plasma acetaminophen concentration of about 200 mumol l-1 for glucose monitoring would lead to a major underestimation (approx. 6 mmol l-1) of subcutaneous glucose concentrations.
Moatti-Sirat
D
D
INSERM U 341, Service de Diabétologie, Hôtel-Dieu, Paris, France.
Velho
G
G
Reach
G
G
D000082:Acetaminophen / Q000737:chemistry*; D000818:Animals; D001205:Ascorbic Acid / Q000737:chemistry*; D015374:Biosensing Techniques; D001786:Blood Glucose / Q000032:analysis; D004347:Drug Interactions; D004566:Electrodes; D005947:Glucose / Q000032:analysis*; D008567:Membranes, Artificial; D008991:Monitoring, Physiologic; D010424:Pentobarbital; D051381:Rats
D001786:Blood Glucose; D008567:Membranes, Artificial; D000082:Acetaminophen; D010424:Pentobarbital; D005947:Glucose; D001205:Ascorbic Acid